Upfront Diagnostics
PrivateLast Round
Grant
Jul 1, 2026
Total Funding Raised
$3.9M
Company Overview
Upfront Diagnostics is a biotechnology company that develops rapid point-of-care diagnostic tests for stroke detection.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Upfront Diagnostics Comparables
Compare Upfront Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ABCDx | 88% | |
| Galaxy CCRO, Inc. | 78% | |
| Sense Neuro Diagnostics | 77% |
Upfront Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2026 | ||||
| Grant | Jun 21, 2025 | ||||
| VC Round | May 12, 2025 | ||||
| Grant | Mar 17, 2025 | ||||
| Grant | Jun 27, 2023 | ||||
Seed | Jun 27, 2023 |
Upfront Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cambridge Enterprise Ventures | VC Round |
| SBRI Healthcare | Seed, Grant, VC Round |
| Centre for Process Innovation | Grant |
| APEX Ventures | Seed |
| Stroke Association | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 22, 2025
Attending the 17th World Stroke Congress in Barcelona, October 22-24, 2025.
- Oct 14, 2025
Launched LVOne, a rapid point-of-care blood test for stroke triage.
Upfront Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Upfront Diagnostics's valuation, stock price, and market status.
Is Upfront Diagnostics a public or private company?
Upfront Diagnostics is a private company.
What is the current stock price of Upfront Diagnostics?
Upfront Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Upfront Diagnostics worth (valuation)?
Valuation information for Upfront Diagnostics is not publicly available.
Can I buy Upfront Diagnostics stock?
Upfront Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Upfront Diagnostics's last funding round?
Upfront Diagnostics's most recent funding round was Grant on June 21, 2025.
Who are the main investors in Upfront Diagnostics?
Key investors in Upfront Diagnostics include Centre for Process Innovation, APEX Ventures.
Will Upfront Diagnostics IPO soon?
No public IPO plans have been announced for Upfront Diagnostics.
How can I track Upfront Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Upfront Diagnostics's secondary market activity and sign up for updates.